CRBU
Caribou Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.88
-0.01 ▼ -0.53%
🌙 3월 13일 5:31 PM ET (한국 3/14 06:31)
$1.88
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.59 | Insider Own | 11.07% | Shs Outstand | 0.10B | Perf Week | 3.3% |
| Market Cap | 0.18B | Forward P/E | - | EPS next Y | -3.85% | Insider Trans | -0.23% | Shs Float | 0.09B | Perf Month | 18.24% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.32 | Inst Own | 36.56% | Short Float | 8.42% | Perf Quarter | -1.05% |
| Income | -0.15B | P/S | 16.28 | EPS this Y | 20.46% | Inst Trans | -0.01% | Short Ratio | 5.88 | Perf Half Y | -1.57% |
| Sales | 0.01B | P/B | 1.46 | EPS next 5Y | 2.65% | ROA | -59.19% | Short Interest | 7.23M | Perf YTD | 18.24% |
| Book/sh | 1.28 | P/C | 1.3 | EPS past 3/5Y | 1.01% -22.62% | ROE | -78.97% | 52W High | -46.82% ($3.54) | Perf Year | 90.77% |
| Cash/sh | 1.44 | P/FCF | - | Sales past 3/5Y | -6.95% -2.03% | ROIC | -99.95% | 52W Low | 184.85% ($0.66) | Perf 3Y | -64.73% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 3.83% | Gross Margin | 67.34% | Volatility(W/M) | 6.3% 8.14% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 6.23 | Sales Y/Y TTM | 11.66% | Oper. Margin | -1220.49% | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.71 | EPS Q/Q | 28.02% | Profit Margin | -1327.4% | RSI (14) | 53.78 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.71 | Sales Q/Q | 89.74% | SMA20 | 1.95% ($1.84) | Beta | 2.51 | Target Price | $11.33 |
| Payout | - | Debt/Eq | 0.22 | Earnings | 3000000 | SMA50 | 12.13% ($1.68) | Rel Volume | 0.62 | Prev Close | $1.89 |
| Employees | 97 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 9.68% 78.57% | SMA200 | 2.99% ($1.83) | Avg Volume(3M) | 1.23M | Price | $1.88 |
| IPO | 2021/7/23 | Option/Short | Yes/Yes | Trades | 3127 | Volume | 760,651 | Change | -0.53% |
뉴스 로딩 중...